Posts by Sandra Ansanay-Alex
Terapet Achieved ISO 13485:2016 certification for its Quality Management System
Terapet’s is a Geneva-based, CERN spinoff, whose proprietary technology is designed to enhance precision in nuclear medicine and radiation therapy by providing advanced imaging and radiation verification solutions. The company is currently developing systems intended to support improved diagnostic accuracy and treatment outcomes in oncology and beyond. “This certification provides a solid foundation as…
Read MoreEAN Congress
The 12th European Academy of Neurology congress is taking place from 27 to 30 June 2026 in Palexpo Geneva. The EAN Congress 2026 will explore the scope of how computing is finding its way into neurological practice. Current technological advances in computing will very rapidly transform clinical medicine and society, and eventually human life. The…
Read MoreWomen in Life Sciences in the Swiss Health Valley
The Swiss Health Valley continues to shine, thanks to the talent, leadership, and vision of extraordinary women shaping the future of medicine and science. Prof. Sophie Pautex, Head of the Department of Rehabilitation and Geriatrics and Chief Physician of the Palliative Care Service at the HUG, has received the EAPC Clinical Impact Award…
Read MoreKYLYS AESTHETICS SA secures CHF 1 Million
The Geneva-based startup and FONGIT alumni develops next-generation hyaluronic acid-based medical devices. KYLYS AESTHETICS SA, a Swiss biotech clinical stage company pioneering high-performance regenerative aesthetic solutions, proudly announces the successful closing of a CHF 1 million fundraising round by existing and new investors. This capital injection will allow the company to advance the development and…
Read MoreMyriad Optics Raises CHF 150’000 from Venture Kick
The EPFL spin-off develops new and disruptive bacterial contamination detection tools that can revolutionize food testing. Testing delays lasting hours to days cost companies millions and expose consumers to health risks. Myriad Optics’ technology targets faster detection to prevent costly recalls and protect public safety. In the food, pharma, and medtech sectors, delays in…
Read MoreClee Medical Wins a W.A. De Vigier Award
Clee Medical, a Wyss Center for Bio and Neuroengineering Geneva spinoff, wins a W.A. De Vigier Award worth CHF 120’000 Clee Medical, a Geneva-based medtech startup, is transforming brain surgery with an advanced platform that combines ultra-high-resolution real-time imaging, AI-based navigation, and machine learning. This technology allows surgeons to operate with extreme precision, reducing…
Read MoreOdne, an EPFL and ETHZ spinoff, raises CHF 4,2 Million in Series A
Odne’s story began through a close collaboration between leading researchers at EPFL and ETHZ, who sought to address long-standing clinical challenges in endodontic therapy. With over CHF 4.2 million raised in its Series A1 round — including support from ZEISS Ventures — and several FDA-cleared products now entering the U.S. market, the medtech company is…
Read MoreMedtech Innovation Event
The MIE, Medtech Innovation Event, is taking place on 31 August 2026 in Switzerland Innovation Park Biel/Bienne (SIPBB) Back for a 12th edition, the Medtech Innovation Event (MIE) 2026 is a matchmaking rendez-vous for SMEs, start-ups, service providers, investors, academia and global players from the Medtech and Healthtech sector. Designed to promote high-quality networking and…
Read MoreNew Lab Spaces Available at Biopôle
Biopôle SA is expanding its offering with 18 brand-new private laboratory units, from 30 to 75 m² each, available from October 2025 in the Trypto building. Since its first building was completed in 2008, Biopôle has grown into a renowned hub with 10 buildings housing over 170 companies and academic institutions such as CHUV…
Read MoreSmart Shoes to Help Prevent Diabetic Foot Amputations
Professor Zoltan Pataky from University of Geneva, has received major funding from the Swiss National Science Foundation (SNSF) to conduct clinical testing on smart shoes designed to prevent foot ulcers in people with diabetes — a leading cause of lower limb amputation. Each year, diabetes leads to an estimated 250,000 amputations in Europe, 85%…
Read More